Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.
NCT ID: NCT06607445
Last Updated: 2024-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
6445 participants
OBSERVATIONAL
2021-05-26
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Intervention to Reduce Medication Errors and Improve Adherence
NCT01291966
Implementation of Pharmacogenetic Testing in Hospital Wards
NCT04573491
Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
NCT05247814
Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)
NCT03322189
Polypharmacy Outpatient Clinic
NCT03911934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lusitania
Primary health care
No interventions assigned to this group
Celtici
Oncology
No interventions assigned to this group
Vettonia
Mental health
No interventions assigned to this group
Turdulia
Internal medicine
No interventions assigned to this group
Lácara
Nephrology
No interventions assigned to this group
Tartessos
Neurology
No interventions assigned to this group
Cancho Roano
Emergencies
No interventions assigned to this group
Oretania
Cardiology
No interventions assigned to this group
Carpetania
Rheumatology
No interventions assigned to this group
Baeturia
Transplants
No interventions assigned to this group
Endovélico
Infectious
No interventions assigned to this group
Sirona
Clinical pharmacology
No interventions assigned to this group
Gaudeamus
University of extremadura
No interventions assigned to this group
Sucellus
Urology
No interventions assigned to this group
Mnemosyne
Neurology-Vascular
No interventions assigned to this group
Paidos
Pediatrics
No interventions assigned to this group
Turuñuelo
Pneumology
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years. In case of minors, they may be included, under the following assumptions:
* If the minor is under 12 years of age, participation will require the consent and signature of the informed consent document by both parents (or their guardian).
* If the minor is between 12 and 16 years of age, a proxy informed consent form will be provided and signed by both parents (if both parents are present at the time of the interview) or only one of them (in which case one of the following two conditions must be stated: that the other parent is not present at the time of the interview but does not object to the participation of the minor in the study or that the signatory is the sole legal guardian of the minor).
* Be registered or potentially/have been attended in the Extremadura Health Service.
* Not have language or communication barrier or present disability being totally dependent on another person.
* Refusal by the patient to be part of the cohort initially, or to continue to be part of the cohort during follow-up.
* Manifest difficulty for follow-up.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Complejo Hospitalario Universitario de Badajoz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Complejo Hospitalario Universitario de Badajoz
Badajoz, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MedeA21.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.